These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8482973)

  • 1. Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function.
    Pantoni L; Inzitari D; Pracucci G; Lolli F; Giordano G; Bracco L; Amaducci L
    J Neurol Sci; 1993 Apr; 115(2):125-31. PubMed ID: 8482973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid.
    Leonardi A; Gandolfo C; Caponnetto C; Arata L; Vecchia R
    J Neurol Sci; 1985 Feb; 67(2):253-61. PubMed ID: 3981221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.
    Frölich L; Kornhuber J; Ihl R; Fritze J; Maurer K; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):363-6. PubMed ID: 1831668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.
    Blennow K; Fredman P; Wallin A; Gottfries CG; Långström G; Svennerholm L
    Eur Neurol; 1993; 33(2):126-8. PubMed ID: 8467818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.
    Elovaara I; Palo J; Erkinjuntti T; Sulkava R
    Eur Neurol; 1987; 26(4):229-34. PubMed ID: 3595662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.
    Elovaara I; Icén A; Palo J; Erkinjuntti T
    J Neurol Sci; 1985 Aug; 70(1):73-80. PubMed ID: 4045502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.
    Alafuzoff I; Adolfsson R; Bucht G; Winblad B
    J Neurol Sci; 1983; 60(3):465-72. PubMed ID: 6631444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF and serum concentrations of albumin and IgG in Alzheimer's disease.
    Kay AD; May C; Papadopoulos NM; Costello R; Atack JR; Luxenberg JS; Cutler NR; Rapoport SI
    Neurobiol Aging; 1987; 8(1):21-5. PubMed ID: 3561662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias.
    Mecocci P; Parnetti L; Reboldi GP; Santucci C; Gaiti A; Ferri C; Gernini I; Romagnoli M; Cadini D; Senin U
    Acta Neurol Scand; 1991 Sep; 84(3):210-3. PubMed ID: 1950463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in 'normal' subjects from the age of 6 months to 30 years.
    Eeg-Olofsson O; Link H; Wigertz A
    Acta Paediatr Scand; 1981 Mar; 70(2):167-70. PubMed ID: 7234400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.
    Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
    Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K
    Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.
    Blennow K; Fredman P; Wallin A; Gottfries CG; Karlsson I; Långström G; Skoog I; Svennerholm L; Wikkelsö C
    Eur Neurol; 1993; 33(2):129-33. PubMed ID: 8467819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation.
    Hampel H; Müller-Spahn F; Berger C; Haberl A; Ackenheil M; Hock C
    Dementia; 1995; 6(6):348-54. PubMed ID: 8563789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients.
    Livrea P; Trojano M; Simone IL; Zimatore GB; Pisicchio L; Logroscino G; Cibelli G
    J Neurol Sci; 1984 Jun; 64(3):245-58. PubMed ID: 6206205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.
    Ahlskog JE; Tyce GM; Kelly PJ; van Heerden JA; Stoddard SL; Carmichael SW
    Exp Neurol; 1989 Aug; 105(2):152-61. PubMed ID: 2753115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pattern of cerebrospinal fluid proteins in infants and children. Determination of normal values (author's transl)].
    Gerbaut L; Ponsot G; Dulac O; Olive G; Arthuis M
    Arch Fr Pediatr; 1981 Jan; 38(1):3-9. PubMed ID: 7224799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier integrity in patients with cerebral infarction investigated by computed tomography and serum-CSF-albumin.
    Al-Kassab S; Skyhøj Olsen T; Skriver EB
    Acta Neurol Scand; 1981 Dec; 64(6):438-45. PubMed ID: 7347999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.